# Hypochloremia, non-medication related associated factors, and impact on clinical outcomes in patients with acute heart failure: Insights from resource limited setups

**Authors:** Belay Mengistu Gebrie, Molla Asnake Kebede, Kedir Negesso Tukeni, Mohammed Mecha Abafogi, Turi Abateka Abadiga, Bethelhem Yaynemsa Sequr, Biniyam Beyene Tabor, Selemon Gebrezgabiher Asgedom, Innocent Chukwuonye, Innocent Chukwuonye, Innocent Chukwuonye

PMC · DOI: 10.1371/journal.pone.0344692 · PLOS One · 2026-03-19

## TL;DR

This study finds that low chloride levels in hospitalized heart failure patients are common and linked to worse outcomes like longer hospital stays and higher mortality.

## Contribution

The study identifies non-medication factors associated with hypochloremia in acute heart failure patients in low-resource settings.

## Key findings

- Hypochloremia was present in 33.1% of acute heart failure patients.
- Hypochloremic patients had longer hospital stays and higher in-hospital mortality.
- Severe heart failure, COPD, hypokalemia, and hyponatremia were independently associated with hypochloremia.

## Abstract

Electrolyte disturbances such as hypochloremia are common in patients with acute heart failure (AHF) and may worsen clinical outcomes. However, data from low-resource settings remain limited. Therefore, the aim of this study is to determine the prevalence of hypochloremia among AHF patients, assess its association with length of hospital stay and in-hospital mortality, and identify factors independently associated with its occurrence.

To determine the prevalence of hypochloremia among patients admitted with acute heart failure, to assess its non-medication association with length of hospital stay and in-hospital mortality, and to identify factors independently associated with hypochloremia in a resource-limited setting.

A retrospective observational cohort study of hospitalized patients with acute heart failure, with serum chloride measured at admission was conducted among 260 patients aged ≥16. Data were analysed using SPSS version 26.0. The association between hypochloremia and clinical outcomes, including in-hospital mortality and length of hospital stay, was assessed using the Chi-square test and the Mann–Whitney U test, respectively. Multivariable logistic regression analysis was performed to identify independent predictors of hypochloremia. A p-value of <0.05 was considered statistically significant.

The prevalence of hypochloremia was 33.1% (95% CI: 27.4%–39.2%), and hypochloremic patients had significantly longer hospital stays (median: 12 days vs. 8.5 days; p = 0.001) and higher in-hospital mortality (χ² = 8.58; p = 0.003). Multivariate analysis showed that NYHA class IV heart failure [AOR = 6.96; 95% CI: 1.49–32.4; p = 0.014], history of COPD [AOR = 4.94; 95% CI: 1.36–17.9; p = 0.001], hyponatremia [AOR = 2.20; 95% CI: 1.8–9.5; p = 0.001], and hypokalemia [AOR = 4.08; 95% CI: 1.53–10.6; p = 0.004] were significantly associated with hypochloremia.

In this study hypochloremia at admission was common and associated with higher in-hospital mortality and longer hospital stays. It was more frequently observed in patients with severe heart failure, COPD, hypokalemia and hyponatremia.

## Linked entities

- **Diseases:** COPD (MONDO:0005002)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}
- **Diseases:** acute (MESH:D000208), Hypokalemia (MESH:D007008), hypertension (MESH:D006973), Electrolyte disturbances (MESH:D014883), Acute Heart Failure (MESH:D006333), ACS (MESH:D000168), dilated cardiomyopathy (MESH:D002311), anemia (MESH:D000740), food (MESH:D005517), chronic kidney disease (MESH:D051436), ischemic heart disease (MESH:D017202), Peripheral Edema (MESH:D004487), respiratory failure (MESH:D012131), COPD (MESH:D029424), HHD (MESH:D016506), diabetes mellitus (MESH:D003920), chronic rheumatic valvular heart disease (MESH:D006349), Hyponatremia (MESH:D007010), diuretic resistance (MESH:D060467), Pulmonary Congestion (MESH:D001261), atrial fibrillation (MESH:D001281), NYHA III (MESH:C537189), acute coronary syndrome (MESH:D054058), neurohormonal dysregulation (MESH:D021081), retroviral infection (MESH:D000071297), C (OMIM:211750), restrictive cardiomyopathy (MESH:D002313), RCMP 4 (MESH:D053632), HFpEF (MESH:D054144), hypoxia (MESH:D000860), HFrEF (MESH:D054143), peripheral enema (MESH:D010523), volume overload (MESH:D019190), JMC (MESH:D000069279), acute and chronic heart failure (MESH:D017114), thyrotoxicosis (MESH:C566386), Death (MESH:D003643), impaired renal function (MESH:D007674)
- **Chemicals:** thiazide (MESH:D049971), aldosterone (MESH:D000450), chlorine (MESH:D002713), potassium (MESH:D011188), sodium (MESH:D012964), creatinine (MESH:D003404), PONE-D-25-64426R1 (-), atorvastatin (MESH:D000069059), chloride (MESH:D002712), aspirin (MESH:D001241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13001925/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13001925/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC13001925/full.md

---
Source: https://tomesphere.com/paper/PMC13001925